Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
Do you feel there is any role for neoadjuvant imatinib in pediatric DFSP with the classic translocation given that surgery can introduce high morbidity?
Related Questions
Do you always pursue testing for NOD2 mutations when you are suspecting a diagnosis of Blau syndrome?
What is your workup for patients presenting with hypopigmented macules?
Have you encountered idiopathic aseptic facial granuloma in areas other than the face?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
After diagnosing genital warts (condyloma accuminatum), do you order an STI panel?
What orals or biologics do you reach for in a child with recalcitrant inverse psoriasis in the groin who has tried and failed topical including steroids, pimecrolimus, zoryve, ketoconazole, and tacrolimus?
Have you found yourself transitioning away from topical steroids to newer age topicals for treatment of atopic dermatitis and psoriasis?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Do certain subtypes of BCC respond better to hedgehog pathway inhibitors?
Do you incorporate laser hair removal into your treatment plan for patients with HS?
